Blog
In-depth breakdowns of every GLP-1 medication on the market, including dosing schedules, side effects, and head-to-head comparisons.
An objective comparison of compounded semaglutide and FDA-approved Wegovy, covering regulatory status, safety, efficacy, cost, and the evolving FDA position on GLP-1 compounding.
An evidence-based comparison of every FDA-approved GLP-1 medication for weight loss, with head-to-head trial data, real-world outcomes, and guidance on choosing the right option with your provider.
Everything known about retatrutide, the triple-agonist weight loss drug in late-stage clinical trials, including Phase 2 data showing up to 24% weight loss, how it compares to semaglutide and tirzepatide, and when it might be available.
Thinking about switching from one GLP-1 medication to another? Here's how dose conversions work, what to expect during the transition, and when switching makes sense.
MedicationsA complete comparison of the new oral Wegovy pill and the traditional Wegovy injection for weight loss, covering efficacy, pricing, convenience, side effects, and which option might be right for you.
A comprehensive comparison of semaglutide and tirzepatide for weight loss, including clinical trial data, side effect profiles, pricing, and a framework for choosing between them with your provider.
